Anthony Miliotto

1.2k total citations
23 papers, 866 citations indexed

About

Anthony Miliotto is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Anthony Miliotto has authored 23 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Anthony Miliotto's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Anthony Miliotto is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Anthony Miliotto collaborates with scholars based in United States, Canada and Poland. Anthony Miliotto's co-authors include Kunle Odunsi, AJ Robert McGray, Ruea‐Yea Huang, Sacha Gnjatic, Junko Matsuzaki, Takemasa Tsuji, Shashikant Lele, Amy Beck, Paulette Mhawech‐Fauceglia and Gerd Ritter and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Anthony Miliotto

21 papers receiving 848 citations

Peers

Countries citing papers authored by Anthony Miliotto

Since Specialization

Citations

This map shows the geographic impact of Anthony Miliotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Miliotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Miliotto more than expected).

Fields of papers citing papers by Anthony Miliotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Miliotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Miliotto. The network helps show where Anthony Miliotto may publish in the future.

Co-authorship network of co-authors of Anthony Miliotto

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Miliotto. A scholar is included among the top collaborators of Anthony Miliotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Miliotto. Anthony Miliotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation 2021 ·Molecular Therapy — Oncolytics ·(unknown), (unknown), M. Winkler, Prashant Kumar Singh, Eduardo Cortes, Anthony Miliotto, Song Liu, Mark D. Long, Yan Li, Aimee Stablewski, Kieran L. O’Loughlin, Hans Minderman, Kunle Odunsi, Hanna Rokita, AJ Robert McGray, Emese Zsíros, Danuta Kozbor	11
2	A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer 2021 ·Cancer Immunology Immunotherapy ·AJ Robert McGray, Cheryl Eppolito, Anthony Miliotto, Kelly L. Singel, Kyle B. Stephenson, Amit A. Lugade, Brahm H. Segal, Tibor Keler, Gill Webster, Brian D. Lichty, Danuta Kozbor, Kunle Odunsi	11
3	Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies 2020 ·Journal for ImmunoTherapy of Cancer ·Adekunle Odunsi, AJ Robert McGray, Anthony Miliotto, Yali Zhang, Jianming Wang, (unknown), Cheryl Eppolito, Ruea‐Yea Huang	19
4	Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer 2019 ·Journal for ImmunoTherapy of Cancer ·AJ Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, Cheryl Eppolito, Anthony Miliotto, Kyle B. Stephenson, Amit A. Lugade, Gill Webster, Brian D. Lichty, Mukund Seshadri, Danuta Kozbor, Kunle Odunsi	45
5	Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy 2018 ·Cancer Immunology Research ·Takemasa Tsuji, (unknown), Junko Matsuzaki, Anthony Miliotto, (unknown), Richard C. Koya, Kunle Odunsi	13
6	Abstract A35: Ovarian cancer stem cells subvert tumor-specific T cells by disrupting T cells’ metabolic fitness 2018 ·Clinical Cancer Research ·Feng Qian, Jianqun Liao, Anthony Miliotto, (unknown), Kunle Odunsi	1
7	Abstract PR12: Epigenetic reprograming promotes an immunogenic ovarian tumor microenvironment and synergizes with adoptive transfer of engineered T cells expressing NY-ESO-1 specific T cell receptors 2018 ·Clinical Cancer Research ·Li Shen, (unknown), Anthony Miliotto, (unknown), Cheryl Eppolito, Junko Matsuzaki, Takemasa Tsuji, Richard C. Koya, Adekunle Odunsi	0
8	NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer 2017 ·Gynecologic Oncology ·J. Brian Szender, Antonios Papanicolau‐Sengos, Kevin H. Eng, Anthony Miliotto, Amit A. Lugade, Sacha Gnjatic, Junko Matsuzaki, Carl D. Morrison, Kunle Odunsi	57
9	Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer 2017 ·Cancer Research ·AJ Robert McGray, Cheryl Eppolito, Anthony Miliotto, (unknown), Kelly L. Singel, Jonathan Pol, Kyle B. Stephenson, Brahm H. Segal, Brian D. Lichty, Kunle Odunsi	0
10	HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer 2016 ·Gynecologic Oncology ·J. Brian Szender, Kevin H. Eng, Junko Matsuzaki, Anthony Miliotto, Sacha Gnjatic, Takemasa Tsuji, Kunle Odunsi	6
11	Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer 2016 ·OncoImmunology ·Ruea‐Yea Huang, (unknown), AJ Robert McGray, Anthony Miliotto, Kunle Odunsi	278
12	Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer 2014 ·Cancer Immunology Research ·Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf	153
13	Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer 2014 ·PLoS ONE ·(unknown), Kevin H. Eng, Paulette Mhawech‐Fauceglia, Carl D. Morrison, Anthony Miliotto, Amy Beck, Junko Matsuzaki, Takemasa Tsuji, Adrienne Groman, Sacha Gnjatic, (unknown), Shashikant Lele, Kunle Odunsi	57
14	Developmentally Restricted Differentiation Antigens Are Targets for Immunotherapy in Epithelial Ovarian Carcinoma 2013 ·International Journal of Gynecological Pathology ·Heidi Godoy, Paulette Mhawech‐Fauceglia, Amy Beck, Anthony Miliotto, Austin Miller, Shashikant Lele, Kunle Odunsi	16
15	Statins Use Prevents Ovarian Cancer Recurrence in Women with Diabetes Mellitus 2013 ·(unknown), (unknown), (unknown), (unknown), Jingjing Yin, Terry Mashtare, Anthony Miliotto, (unknown), Kunle Odunsi, (unknown)	2
16	Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus. 2013 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Jingjing Yin, Terry Mashtare, Anthony Miliotto, (unknown), Kunle Odunsi, (unknown)	2
17	A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation 2012 ·International Journal of Oncology ·(unknown), (unknown), (unknown), (unknown), Anthony Miliotto, Lloyd J. Old, Kunle Odunsi, Sang‐Yull Lee	8
18	NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer 2012 ·PLoS ONE ·Foluso O. Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B. Edge, Christine B. Ambrosone, Tracey L. O’Connor, Ellis Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi	75
19	Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors 2011 ·PLoS ONE ·Takemasa Tsuji, Junko Matsuzaki, Erika Ritter, Anthony Miliotto, Gerd Ritter, Kunle Odunsi, Lloyd J. Old, Sacha Gnjatic	14
20	Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. 2009 ·PubMed ·Nana Tchabo, Paulette Mhawech‐Fauceglia, Otávia L. Caballero, Jeannine Villella, Amy Beck, Anthony Miliotto, Jianqun Liao, Chris Andrews, Shashikant Lele, Lloyd J. Old, Kunle Odunsi	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact